Altimmune, Inc. (ALT)
USD 5.77
(11.61%)
USD 5.77
(11.61%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -65.37 Million USD | 62.5% |
| 2022 | -136 Thousand USD | -103.52% |
| 2021 | 3.85 Million USD | 115.24% |
| 2020 | -25.32 Million USD | -124.82% |
| 2019 | -11.26 Million USD | -38.58% |
| 2018 | -8.12 Million USD | 55.74% |
| 2017 | -18.36 Million USD | -822.27% |
| 2016 | -1.99 Million USD | -135.7% |
| 2015 | 5.57 Million USD | -5.88% |
| 2014 | 5.92 Million USD | -66.92% |
| 2013 | 17.91 Million USD | -28.85% |
| 2012 | 25.17 Million USD | 3.75% |
| 2011 | 24.26 Million USD | 15.59% |
| 2010 | 20.99 Million USD | -23.8% |
| 2009 | 27.54 Million USD | -16.29% |
| 2008 | 32.91 Million USD | 124.75% |
| 2007 | 14.64 Million USD | 692.53% |
| 2006 | 1.84 Million USD | 292.23% |
| 2005 | 471.07 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -102 Thousand USD | 94.5% |
| 2024 Q2 | -56 Thousand USD | 45.1% |
| 2023 Q2 | -13.24 Million USD | -3613.79% |
| 2023 Q1 | 377 Thousand USD | 271.36% |
| 2023 Q4 | -1.85 Million USD | 89.72% |
| 2023 Q3 | -18.02 Million USD | -36.08% |
| 2023 FY | -51 Thousand USD | 62.5% |
| 2022 Q1 | -87 Thousand USD | 99.51% |
| 2022 FY | -136 Thousand USD | -103.52% |
| 2022 Q4 | -220 Thousand USD | 98.91% |
| 2022 Q3 | -20.26 Million USD | -26.74% |
| 2022 Q2 | -15.98 Million USD | -18273.56% |
| 2021 Q3 | -29.04 Million USD | -121.16% |
| 2021 Q4 | -17.76 Million USD | 38.84% |
| 2021 FY | 3.85 Million USD | 115.24% |
| 2021 Q1 | -10.16 Million USD | 19.95% |
| 2021 Q2 | -13.13 Million USD | -29.27% |
| 2020 Q2 | -15.87 Million USD | -392.2% |
| 2020 Q3 | -14.1 Million USD | 11.14% |
| 2020 Q4 | -12.69 Million USD | 10.01% |
| 2020 Q1 | -3.22 Million USD | -101.89% |
| 2020 FY | -25.32 Million USD | -124.82% |
| 2019 Q4 | -1.59 Million USD | 80.25% |
| 2019 FY | -11.26 Million USD | -38.58% |
| 2019 Q1 | -262.07 Thousand USD | 44.95% |
| 2019 Q2 | -1.31 Million USD | -403.31% |
| 2019 Q3 | -8.08 Million USD | -512.99% |
| 2018 Q4 | -476.04 Thousand USD | 77.27% |
| 2018 Q3 | -2.09 Million USD | 16.29% |
| 2018 FY | -8.12 Million USD | 55.74% |
| 2018 Q1 | -5.74 Million USD | -247.77% |
| 2018 Q2 | -2.5 Million USD | 56.43% |
| 2017 Q2 | -5.24 Million USD | -164.87% |
| 2017 Q1 | -1.98 Million USD | -57.67% |
| 2017 FY | -18.36 Million USD | -822.27% |
| 2017 Q4 | -1.65 Million USD | -25.69% |
| 2017 Q3 | -1.31 Million USD | 74.98% |
| 2016 Q3 | -1.4 Million USD | -292.81% |
| 2016 FY | -1.99 Million USD | -135.7% |
| 2016 Q2 | 729.74 Thousand USD | 1381.96% |
| 2016 Q1 | -56.92 Thousand USD | 79.5% |
| 2016 Q4 | -1.25 Million USD | 10.66% |
| 2015 Q1 | 7.06 Million USD | 287.05% |
| 2015 Q3 | -490.56 Thousand USD | -142.67% |
| 2015 Q4 | -277.66 Thousand USD | 43.4% |
| 2015 FY | 5.57 Million USD | -5.88% |
| 2015 Q2 | 1.14 Million USD | -83.74% |
| 2014 Q3 | 962.45 Thousand USD | -73.7% |
| 2014 FY | 5.92 Million USD | -66.92% |
| 2014 Q4 | 1.82 Million USD | 89.75% |
| 2014 Q2 | 3.65 Million USD | -2.23% |
| 2014 Q1 | 3.74 Million USD | 2.42% |
| 2013 Q1 | 6.47 Million USD | 7.67% |
| 2013 Q4 | 3.65 Million USD | 4.75% |
| 2013 Q3 | 3.48 Million USD | -18.79% |
| 2013 Q2 | 4.29 Million USD | -33.66% |
| 2013 FY | 17.91 Million USD | -28.85% |
| 2012 FY | 25.17 Million USD | 3.75% |
| 2012 Q3 | 6.69 Million USD | 6.0% |
| 2012 Q4 | 6.01 Million USD | -10.19% |
| 2012 Q1 | 6.14 Million USD | -1.45% |
| 2012 Q2 | 6.31 Million USD | 2.73% |
| 2011 FY | 24.26 Million USD | 15.59% |
| 2011 Q2 | 6.42 Million USD | 1.44% |
| 2011 Q3 | 5.26 Million USD | -18.18% |
| 2011 Q4 | 6.23 Million USD | 18.62% |
| 2011 Q1 | 6.33 Million USD | -7.53% |
| 2010 Q2 | 4.77 Million USD | 53.36% |
| 2010 FY | 20.99 Million USD | -23.8% |
| 2010 Q1 | 3.11 Million USD | -56.27% |
| 2010 Q3 | 6.24 Million USD | 30.63% |
| 2010 Q4 | 6.85 Million USD | 9.78% |
| 2009 Q1 | 5.52 Million USD | 0.76% |
| 2009 FY | 27.54 Million USD | -16.29% |
| 2009 Q4 | 7.12 Million USD | 4.33% |
| 2009 Q3 | 6.83 Million USD | -15.37% |
| 2009 Q2 | 8.07 Million USD | 46.17% |
| 2008 FY | 32.91 Million USD | 124.75% |
| 2008 Q1 | 5.84 Million USD | -2.06% |
| 2008 Q4 | 5.48 Million USD | -48.67% |
| 2008 Q3 | 10.67 Million USD | -2.18% |
| 2008 Q2 | 10.91 Million USD | 86.88% |
| 2007 Q2 | 2.24 Million USD | 362.27% |
| 2007 FY | 14.64 Million USD | 692.53% |
| 2007 Q4 | 5.96 Million USD | 76.84% |
| 2007 Q3 | 3.37 Million USD | 50.0% |
| 2007 Q1 | 486.31 Thousand USD | -1.19% |
| 2006 Q3 | 484.48 Thousand USD | 3.96% |
| 2006 Q4 | 492.15 Thousand USD | 1.58% |
| 2006 Q2 | 466.04 Thousand USD | 15.07% |
| 2006 Q1 | 405.02 Thousand USD | 6.64% |
| 2006 FY | 1.84 Million USD | 292.23% |
| 2005 Q4 | 379.81 Thousand USD | 84.14% |
| 2005 FY | 471.07 Thousand USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | 206.26 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Absci Corporation | -41.84 Million USD | -56.212% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 169.015% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 104.307% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -128739.18% |
| Apollomics, Inc. | 127 Thousand USD | 51574.803% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -61762.314% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -284130.435% |
| Bicycle Therapeutics plc | -129.52 Million USD | 49.527% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 8251.247% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 54577.5% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 426.017% |
| Chimerix, Inc. | 324 Thousand USD | 20276.852% |
| CRISPR Therapeutics AG | 240.95 Million USD | 127.131% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 231.258% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 257.959% |
| Fortress Biotech, Inc. | 57.85 Million USD | 212.998% |
| Fortress Biotech, Inc. | 57.85 Million USD | 212.998% |
| Gritstone bio, Inc. | -6.26 Million USD | -944.297% |
| Allakos Inc. | -6.14 Million USD | -964.533% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -6731.034% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 541.889% |
| Cytokinetics, Incorporated | -322.59 Million USD | 79.735% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -37256.0% |
| Innoviva, Inc. | 261.06 Million USD | 125.041% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -572945.231% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -1740.974% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -650312.894% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -7320.318% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -16284.211% |
| ImmuCell Corporation | 4.39 Million USD | 1587.006% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 38.399% |
| Incyte Corporation | 3.44 Billion USD | 101.9% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -2347.027% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 33674.892% |
| Mustang Bio, Inc. | -2.22 Million USD | -2838.112% |
| MiMedx Group, Inc. | 266.84 Million USD | 124.499% |
| MEI Pharma, Inc. | 49.32 Million USD | 232.53% |
| MacroGenics, Inc. | 50.52 Million USD | 229.382% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Mereo BioPharma Group plc | 7.42 Million USD | 980.326% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -820.014% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 324.997% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 146.628% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -210903.163% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -67294.845% |
| NextCure, Inc. | -3.68 Million USD | -1674.511% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 2639.744% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 443.291% |
| Onconetix, Inc. | -1.12 Million USD | -5699.772% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -125.673% |
| Opthea Limited | 21.72 Thousand USD | 301080.663% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -5325.686% |
| Psyence Biomedical Ltd. | -240.00 USD | -27238650.0% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -113937.261% |
| Precigen, Inc. | 106 Thousand USD | 61772.642% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 6578.989% |
| Prime Medicine, Inc. | -147.9 Million USD | 55.801% |
| PureTech Health plc | -1.6 Million USD | -3978.166% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -821.006% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.578% |
| Replimune Group, Inc. | -2.65 Million USD | -2362.26% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -260880.478% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 159.553% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -12550.896% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 83.643% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sesen Bio, Inc. | 40 Million USD | 263.433% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -44.232% |
| Solid Biosciences Inc. | -76.56 Million USD | 14.615% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -544675.0% |
| SciSparc Ltd. | 2.19 Million USD | 3076.913% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -144.898% |
| TG Therapeutics, Inc. | 219.1 Million USD | 129.836% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 2259.663% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -3680.972% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 148.863% |
| UroGen Pharma Ltd. | 73.35 Million USD | 189.122% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1593.216% |
| XOMA Corporation | 3.86 Million USD | 1793.162% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -4606.479% |
| AbCellera Biologics Inc. | 38.02 Million USD | 271.921% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1307360.0% |
| Cassava Sciences, Inc. | -89.42 Million USD | 26.895% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -109.746% |
| Precision BioSciences, Inc. | 40.47 Million USD | 261.526% |
| Dyadic International, Inc. | 922.95 Thousand USD | 7182.995% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -44371.429% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 410.398% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 15518.16% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -652.538% |
| IGM Biosciences, Inc. | -211.66 Million USD | 69.114% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -3175.2% |
| Acelyrin, Inc. | -115 Thousand USD | -56746.087% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 2784.723% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 154.59% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -389.398% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 142.233% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 33.44% |
| Senti Biosciences, Inc. | -2.68 Million USD | -2336.564% |
| Mesoblast Limited | -9.81 Million USD | -566.052% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 40.833% |
| ChromaDex Corporation | 50.78 Million USD | 228.738% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 154.263% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Seer, Inc. | 7.02 Million USD | 1030.312% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 148.328% |
| Novavax, Inc. | 639.93 Million USD | 110.216% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 33.404% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -50.411% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 50386.923% |
| Celcuity Inc. | -142.77 Thousand USD | -45688.39% |
| ContextLogic Inc. | 59 Million USD | 210.802% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 12793.786% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 494.36% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 101.924% |
| Amarin Corporation plc | 165.54 Million USD | 139.491% |
| AnaptysBio, Inc. | 14.78 Million USD | 542.277% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -11429.63% |
| Aptorum Group Limited | -1.11 Million USD | -5764.69% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 367.363% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 127.156% |
| Ardelyx, Inc. | 106.66 Million USD | 161.29% |
| Celularity Inc. | 6.75 Million USD | 1067.772% |
| Omeros Corporation | -69.77 Million USD | 6.314% |
| Humacyte, Inc. | -76.55 Million USD | 14.601% |
| Immunocore Holdings plc | 248.39 Million USD | 126.319% |
| IO Biotech, Inc. | -756 Thousand USD | -8547.222% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -4484.362% |
| Summit Therapeutics Inc. | -2.05 Million USD | -3088.927% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1262.505% |
| Pulmatrix, Inc. | -8.22 Million USD | -695.292% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 83.607% |
| Evogene Ltd. | 1.39 Million USD | 4772.838% |
| CorMedix Inc. | -205.56 Thousand USD | -31702.084% |
| BioLineRx Ltd. | 1.1 Million USD | 6000.09% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 13280.04% |
| Sagimet Biosciences Inc. | 2 Million USD | 3368.65% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 107.494% |
| scPharmaceuticals Inc. | 9.78 Million USD | 768.299% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 5.251% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 113.737% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -572945.231% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -225324.138% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -34488.889% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 1713.75% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -12352.0% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -147842.88% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -525.881% |
| Daré Bioscience, Inc. | 2.76 Million USD | 2460.443% |
| bluebird bio, Inc. | -4.03 Million USD | -1522.159% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 103.433% |
| DBV Technologies S.A. | 15.72 Million USD | 515.647% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 63.964% |
| Galecto, Inc. | -830 Thousand USD | -7776.265% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -11348.862% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -66.162% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 10834.483% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -45519.361% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 219.689% |
| ADMA Biologics, Inc. | 88.21 Million USD | 174.104% |
| Clene Inc. | 533 Thousand USD | 12365.103% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 3388.38% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -13675.933% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -628486.538% |
| Soligenix, Inc. | 97.31 Thousand USD | 67279.456% |
| Century Therapeutics, Inc. | -10.8 Million USD | -504.802% |
| Kura Oncology, Inc. | -849 Thousand USD | -7600.0% |
| Surrozen, Inc. | -27.23 Million USD | -140.077% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 2.58% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 166.007% |
| Autolus Therapeutics plc | -4.86 Million USD | -1243.189% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -38812.5% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 15.754% |
| GRI Bio, Inc. | 10.84 Million USD | 703.016% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 2673.754% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -39.57% |
| INmune Bio, Inc. | 155 Thousand USD | 42276.129% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 205.544% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -4239.998% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -9981.363% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -863479.921% |
| Jaguar Health, Inc. | 7.72 Million USD | 946.362% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -223214.204% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 16361.94% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 930.555% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -20785.942% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 169.206% |
| Verastem, Inc. | -62 Thousand USD | -105340.323% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -24947.126% |
| Histogen Inc. | 3.76 Million USD | 1834.492% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 11445.953% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 109.604% |
| Surrozen, Inc. | -27.23 Million USD | -140.077% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1113.082% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -3301566.667% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1177.62% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -97281.24% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 44937.449% |
| Kronos Bio, Inc. | 1.37 Million USD | 4864.796% |
| Turnstone Biologics Corp. | 16.5 Million USD | 496.056% |
| Synaptogenix, Inc. | -6347.00 USD | -1029882.669% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -128082.353% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 324.426% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 140.513% |
| Exelixis, Inc. | 1.75 Billion USD | 103.719% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 41.715% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 119.336% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -5800.09% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -55071.279% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 993.318% |
| Insmed Incorporated | 239.63 Million USD | 127.28% |
| MediWound Ltd. | 3.57 Million USD | 1927.082% |
| OmniAb, Inc. | 14.66 Million USD | 545.715% |
| Alector, Inc. | -95.05 Million USD | 31.225% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 152.04% |
| Zai Lab Limited | 170.9 Million USD | 138.252% |
| AlloVir, Inc. | -398 Thousand USD | -16325.377% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 179.843% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -6234.593% |
| Aura Biosciences, Inc. | -1.29 Million USD | -4948.108% |
| Immunic, Inc. | -111 Thousand USD | -58794.595% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 512.344% |
| Veracyte, Inc. | 248.14 Million USD | 126.344% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 99.065% |
| FibroGen, Inc. | 128.9 Million USD | 150.714% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 120.841% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -11590857.447% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -460.33% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 16905.398% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 118.397% |
| Fortrea Holdings Inc. | 424 Million USD | 115.418% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 24.132% |
| XBiotech Inc. | -1.74 Million USD | -3648.452% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -5800.09% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -9745.331% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -40.675% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 13.452% |
| Agenus Inc. | 139.61 Million USD | 146.824% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 189.06% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 489.056% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 116.804% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -31.676% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 120.007% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -477.304% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 32.57% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1210711.111% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -97724.233% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -37289.544% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -17379.412% |
| Ainos, Inc. | -253.73 Thousand USD | -25664.485% |
| Pluri Inc. | 322 Thousand USD | 20402.174% |
| Prothena Corporation plc | -129.2 Million USD | 49.402% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 229.647% |
| Rallybio Corporation | -150 Thousand USD | -43482.0% |
| Kodiak Sciences Inc. | -25.94 Million USD | -151.948% |
| Cue Biopharma, Inc. | -32.6 Million USD | -100.488% |
| MeiraGTx Holdings plc | 287 Thousand USD | 22878.049% |
| Annexon, Inc. | -3.26 Million USD | -1901.01% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -56.631% |
| Moderna, Inc. | 2.15 Billion USD | 103.034% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -330.964% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 204.795% |
| Blueprint Medicines Corporation | 236.58 Million USD | 127.632% |
| Immix Biopharma, Inc. | -5468.00 USD | -1195455.962% |
| CalciMedica, Inc. | -58 Thousand USD | -112612.069% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -950.675% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -2198.629% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 162.799% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -111.803% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -5487.436% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 2455.287% |
| Nutriband Inc. | 862.1 Thousand USD | 7682.951% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -19070.968% |
| Vor Biopharma Inc. | -3.49 Million USD | -1772.079% |
| Roivant Sciences Ltd. | 109.23 Million USD | 159.846% |
| Alkermes plc | 1.37 Billion USD | 104.756% |
| ProKidney Corp. | -3.16 Million USD | -1962.891% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -48.873% |
| Arcellx, Inc. | 108.27 Million USD | 160.375% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1053.376% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 16.903% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -198000.0% |
| Atai Life Sciences N.V. | -5000.00 USD | -1307360.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -53546.427% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -67996.875% |
| MediciNova, Inc. | 979.7 Thousand USD | 6772.723% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 22.469% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -69037.539% |
| GeoVax Labs, Inc. | -20.72 Million USD | -215.495% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 126.734% |
| Biomea Fusion, Inc. | -4.2 Million USD | -1456.129% |
| RenovoRx, Inc. | - USD | Infinity% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -20988.065% |
| Geron Corporation | -123.5 Million USD | 47.068% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1307360.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 14.403% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -2556.359% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 130.586% |
| Royalty Pharma plc | 1.79 Billion USD | 103.644% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -6847.184% |
| Imunon, Inc. | -720 Thousand USD | -8979.52% |
| BioAtla, Inc. | -103.73 Million USD | 36.978% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 73.077% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -20920.257% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 41.324% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -6787.357% |
| 89bio, Inc. | -273 Thousand USD | -23846.154% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 6.723% |
| aTyr Pharma, Inc. | -2.38 Million USD | -2637.563% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 624.663% |
| Viridian Therapeutics, Inc. | -1 Million USD | -6385.417% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 502869330.769% |
| Akari Therapeutics, Plc | -4000.00 USD | -1634225.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 110.264% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 5942.091% |
| Liquidia Corporation | 14.6 Million USD | 547.76% |
| Entera Bio Ltd. | -56 Thousand USD | -116637.5% |
| GH Research PLC | -315 Thousand USD | -20653.333% |
| Vericel Corporation | 135.57 Million USD | 148.219% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -17.664% |
| Xencor, Inc. | -85.26 Million USD | 23.325% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -29483.622% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -9981.363% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -6429.23% |
| Vaxcyte, Inc. | -75 Million USD | 12.836% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 60.974% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 136.759% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 33674.892% |
| Portage Biotech Inc. | -54 Thousand USD | -120961.111% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -69037.539% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -17240.318% |
| OncoCyte Corporation | 413 Thousand USD | 15928.814% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1454249.277% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -29447197.297% |
| Purple Biotech Ltd. | -196 Thousand USD | -33253.571% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -17058.268% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -197.326% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 195.959% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 828.959% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -51374.803% |
| United Therapeutics Corporation | 2.07 Billion USD | 103.158% |
| HilleVax, Inc. | -2.15 Million USD | -2932.143% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 98755.378% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -1558.351% |
| Pharming Group N.V. | 220.1 Million USD | 129.701% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -435603.812% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -9686.377% |
| Pyxis Oncology, Inc. | -2 Million USD | -3168.65% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -870824.681% |
| Savara Inc. | -44.26 Million USD | -47.696% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -79623.171% |
| Curis, Inc. | 9.81 Million USD | 766.324% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -52287.249% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -28572.368% |
| BeiGene, Ltd. | 2.07 Billion USD | 103.145% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 215.321% |
| Erasca, Inc. | -3.73 Million USD | -1651.688% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -231571.274% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -231571.274% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -7044.59% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 916.55% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -12096.455% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 41.173% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -1721.99% |
| Adicet Bio, Inc. | -6.09 Million USD | -972.04% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 118.057% |
| Aditxt, Inc. | -111.66 Thousand USD | -58446.48% |
| Adagene Inc. | 18.11 Million USD | 460.948% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 13496.107% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 141.418% |
| Compugen Ltd. | 31.45 Million USD | 307.83% |
| Generation Bio Co. | -73.91 Million USD | 11.552% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -14859.497% |
| Invivyd, Inc. | -2.02 Million USD | -3123.521% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 78.27% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -63100.178% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 167.837% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 166.512% |
| Instil Bio, Inc. | -4.75 Million USD | -1274.537% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 371.154% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 5861.868% |
| GeoVax Labs, Inc. | -20.72 Million USD | -215.495% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -33542.623% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -7719.737% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 178.371% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 89514.87% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 222.969% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 62.253% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -18419.263% |
| Cingulate Inc. | -582.91 Thousand USD | -11114.785% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -210780.645% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -231.859% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -6516.7% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -115928.895% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -21.815% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -22288.014% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -12304.744% |
| ImmunityBio, Inc. | -17.89 Million USD | -265.416% |
| Korro Bio, Inc. | -3.63 Million USD | -1700.909% |
| Kineta, Inc. | 5.43 Million USD | 1303.258% |
| BioVie Inc. | -229.37 Thousand USD | -28400.242% |
| Codexis, Inc. | 57.33 Million USD | 214.021% |
| Celularity Inc. | 6.75 Million USD | 1067.772% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -54835.294% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 1729.031% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 129321.19% |
| Cibus, Inc. | 1.42 Million USD | 4697.257% |
| IN8bio, Inc. | -2.5 Million USD | -2513.874% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -3098.288% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 10314.531% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 108.397% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 137.798% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Elevation Oncology, Inc. | -39 Thousand USD | -167523.077% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -3340.684% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -101.962% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 182.537% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -209.063% |
| Moolec Science SA | -143.3 Thousand USD | -45518.087% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -54.48% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 2088.835% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 6.73% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -3358.889% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -1809783.721% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 28352.179% |
| Humacyte, Inc. | -76.55 Million USD | 14.601% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -5100.716% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -7609.08% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -53048.78% |
| Notable Labs, Ltd. | 113 Thousand USD | 57952.212% |
| Immunovant, Inc. | -231 Thousand USD | -28200.0% |
| Quantum-Si incorporated | 488 Thousand USD | 13496.107% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -217810.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 3610.902% |
| Acasti Pharma Inc. | -11 Thousand USD | -594200.0% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -31848.958% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -3238.764% |
| PepGen Inc. | -1.18 Million USD | -5421.368% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -185.509% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -79060.36% |
| Immuneering Corporation | -764.13 Thousand USD | -8455.13% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Belite Bio, Inc | -399 Thousand USD | -16284.211% |
| XOMA Corporation | 3.86 Million USD | 1793.162% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -226.278% |
| Bionomics Limited | -434.44 Thousand USD | -14947.336% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -5986.872% |
| uniQure N.V. | 2.21 Million USD | 3051.377% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 28.996% |
| Forte Biosciences, Inc. | -9000.00 USD | -726266.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -7729.102% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -14859.497% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -2615.953% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -5986.872% |
| Peak Bio, Inc. | 367.76 Thousand USD | 17875.56% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 366.654% |
| Benitec Biopharma Inc. | 108 Thousand USD | 60630.556% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -83711.538% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -5334.165% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -3487.98% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -5334.165% |
| argenx SE | 1.1 Billion USD | 105.898% |
| Immunome, Inc. | -8.9 Million USD | -633.951% |
| Verona Pharma plc | -679.62 Thousand USD | -9518.995% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -37256.0% |
| Shattuck Labs, Inc. | -2.38 Million USD | -2641.006% |
| CervoMed Inc. | -1.29 Million USD | -4953.466% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1268.495% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 2745.609% |
| Moolec Science SA | -143.3 Thousand USD | -45518.087% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -15921.616% |
| Design Therapeutics, Inc. | -537 Thousand USD | -12073.743% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -15209.836% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 3146.272% |
| Achilles Therapeutics plc | -4.73 Million USD | -1281.723% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -43.526% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 152130.233% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -7852.92% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -496730.825% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -198000.0% |
| Beam Therapeutics Inc. | -59.67 Million USD | -9.554% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 146.918% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 403.425% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -21911.111% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1523.352% |
| NeurAxis, Inc. | 2.15 Million USD | 3131.153% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -583.389% |
| Lumos Pharma, Inc. | 2 Million USD | 3357.25% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 306.493% |
| Palisade Bio, Inc. | 246 Thousand USD | 26674.39% |
| Nutriband Inc. | 862.1 Thousand USD | 7682.951% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 564.297% |
| Neurogene Inc. | -3.26 Million USD | -1904.077% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -118760.0% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -1670.666% |
| Athira Pharma, Inc. | -969 Thousand USD | -6646.44% |
| HCW Biologics Inc. | -574.82 Thousand USD | -11272.698% |
| XOMA Corporation | 3.86 Million USD | 1793.162% |
| Nektar Therapeutics | 53.47 Million USD | 222.243% |
| Arvinas, Inc. | 71.8 Million USD | 191.049% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 21.672% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -4.139% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -20202.174% |
| Rezolute, Inc. | -36 Thousand USD | -181491.667% |
| Clene Inc. | 533 Thousand USD | 12365.103% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -5091255.14% |
| BeyondSpring Inc. | 1.75 Million USD | 3833.467% |
| Synlogic, Inc. | -1.92 Million USD | -3297.765% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -176583.784% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -932.423% |
| Peak Bio, Inc. | 367.76 Thousand USD | 17875.56% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -244.74% |
| Krystal Biotech, Inc. | 47.6 Million USD | 237.324% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 146.334% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1400.955% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -2424.815% |
| MannKind Corporation | 136.19 Million USD | 148.001% |
| Ikena Oncology, Inc. | -50.49 Million USD | -29.472% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 160.078% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1390.832% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -25841.667% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1307360.0% |
| Legend Biotech Corporation | 140.92 Million USD | 146.387% |
| Mural Oncology plc | -2.56 Million USD | -2446.669% |
| Disc Medicine, Inc. | -100 Thousand USD | -65273.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 414.99% |
| REGENXBIO Inc. | 53.02 Million USD | 223.278% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1120.339% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -33882.066% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -3674.423% |
| Vaxart, Inc. | -60.76 Million USD | -7.587% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -24777.464% |
| Cellectis S.A. | 18 Thousand USD | 363283.333% |
| Longeveron Inc. | 221 Thousand USD | 29680.543% |
| Repare Therapeutics Inc. | -80.07 Million USD | 18.355% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 105.981% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -4952.009% |
| Revolution Medicines, Inc. | -399.66 Million USD | 83.643% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -186680.0% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 133514.286% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.76% |
| Denali Therapeutics Inc. | -93.34 Million USD | 29.966% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -260880.478% |
| Veru Inc. | 7.56 Million USD | 964.045% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -43193.377% |
| Cingulate Inc. | -582.91 Thousand USD | -11114.785% |
| Passage Bio, Inc. | -3.72 Million USD | -1656.866% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -542684.789% |
| Exicure, Inc. | -1.42 Million USD | -4494.027% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -16968.668% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 2518.535% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -12651.353% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -43596.485% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -10.416% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 16819.437% |
| OmniAb, Inc. | 14.66 Million USD | 545.715% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 426.979% |
| Lipocine Inc. | -2.85 Million USD | -2193.131% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -3447.097% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1045.89% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -4239.998% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 186.798% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -100473.846% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 177.552% |
| Ocugen, Inc. | -33.53 Million USD | -94.928% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -1967.457% |
| Q32 Bio Inc. | 578 Thousand USD | 11410.208% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -24569.057% |
| Alumis Inc. Common Stock | -1.28 Million USD | -4991.355% |
| Equillium, Inc. | 35.95 Million USD | 281.804% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -3729.701% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 13156.869% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1581249.782% |
| Dominari Holdings Inc. | 2.03 Million USD | 3306.13% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -35531.244% |
| vTv Therapeutics Inc. | -13.59 Million USD | -380.861% |
| Bio-Techne Corporation | 773.07 Million USD | 108.456% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 477.464% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 114.187% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -5492.216% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -172.615% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 658.887% |
| Nkarta, Inc. | -5.86 Million USD | -1013.869% |
| BioCardia, Inc. | -7.24 Million USD | -801.821% |
| Iterum Therapeutics plc | -1.75 Million USD | -3635.6% |